Only differences in γGT levels tended towards significance (t (35) = −1.916, p = 0.064), with progressive patients presenting a mean level of 184 U/l and stable patients without the need for BMZ treatment 113 U/l.
Group differences regarding the levels of IgE and serological markers at initial presentation were impressive and highly significant (c.f.
The close correlation with size might explain why some markers failed to reach significance in the multivariate analysis, except for a negative Em2+ which increased the odds for controlled disease by 75%.